Medistim ASA
OSE:MEDI.OL
204 (NOK) • At close November 17, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) NOK.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 526.364 | 486.262 | 417.817 | 356.208 | 356.914 | 323.01 | 296.054 | 262.673 | 249.97 | 214.251 | 190.333 | 181.974 | 159.619 | 156.801 | 156.87 | 140.29 | 126.853 | 97.599 | 80.765 | 75.368 |
Cost of Revenue
| 298.534 | 106.486 | 97.114 | 76.577 | 80.139 | 79.38 | 72.782 | 64.958 | 64.653 | 55.572 | 49.189 | 49.442 | 42.242 | 42.776 | 42.792 | 40.622 | 37.965 | 0 | 0 | 0 |
Gross Profit
| 227.83 | 379.776 | 320.703 | 279.631 | 276.775 | 243.63 | 223.272 | 197.715 | 185.317 | 158.679 | 141.144 | 132.532 | 117.377 | 114.025 | 114.078 | 99.668 | 88.888 | 97.599 | 80.765 | 75.368 |
Gross Profit Ratio
| 0.433 | 0.781 | 0.768 | 0.785 | 0.775 | 0.754 | 0.754 | 0.753 | 0.741 | 0.741 | 0.742 | 0.728 | 0.735 | 0.727 | 0.727 | 0.71 | 0.701 | 1 | 1 | 1 |
Reseach & Development Expenses
| 29 | 13.9 | 14.5 | 14.6 | 7.8 | 6.4 | 6.4 | 5.7 | 4.2 | 7.152 | 7.153 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 42.167 | 31.032 | 28.462 | 23.921 | 20.492 | 19.714 | 40.596 | 16.257 | 16.106 | 10.972 | 10.961 | 11.021 | 0 | 51.163 | 51.696 | 42.373 | 37.671 | 0 | 0 | 0 |
Selling & Marketing Expenses
| 9.717 | 8.506 | 4.103 | 3.105 | 7.918 | 6.829 | 4.387 | 6.05 | 4.417 | 5.566 | 6.353 | 5.257 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SG&A
| 67.388 | 39.538 | 32.565 | 27.026 | 28.41 | 26.543 | 44.983 | 22.307 | 20.523 | 16.538 | 17.314 | 16.278 | 0 | 51.163 | 51.696 | 42.373 | 37.671 | 0 | 0 | 0 |
Other Expenses
| 225.505 | 198.989 | 171.863 | 157.12 | 158.598 | 143.109 | 157.801 | 119.054 | 111.788 | 98.78 | 88.225 | 75.126 | 93.514 | 2.347 | 33.86 | 32.94 | 31.22 | 1.282 | 1.259 | 0.849 |
Operating Expenses
| 96.388 | 238.527 | 204.428 | 184.146 | 187.008 | 169.652 | 157.801 | 141.361 | 132.311 | 115.318 | 105.539 | 91.404 | 93.514 | 89.821 | 85.556 | 75.313 | 68.891 | 1.282 | 1.259 | 0.849 |
Operating Income
| 131.442 | 141.251 | 116.278 | 95.485 | 89.768 | 73.977 | 65.47 | 56.355 | 50.257 | 43.362 | 35.605 | 41.127 | 23.864 | 24.204 | 28.522 | 24.355 | 19.997 | 96.317 | 79.506 | 74.519 |
Operating Income Ratio
| 0.25 | 0.29 | 0.278 | 0.268 | 0.252 | 0.229 | 0.221 | 0.215 | 0.201 | 0.202 | 0.187 | 0.226 | 0.15 | 0.154 | 0.182 | 0.174 | 0.158 | 0.987 | 0.984 | 0.989 |
Total Other Income Expenses Net
| 3.77 | 4.798 | -2.207 | -3.878 | 1.276 | 0.501 | 1.141 | -2.827 | 2.639 | 1.531 | 1.883 | 0.524 | -1.602 | 0.397 | 8.682 | -2.755 | -1.089 | 0 | 0 | 0 |
Income Before Tax
| 135.212 | 146.049 | 114.071 | 91.607 | 91.044 | 74.479 | 66.612 | 53.527 | 55.645 | 44.892 | 37.488 | 41.652 | 22.261 | 24.601 | 37.204 | 21.6 | 18.908 | 0 | 0 | 0 |
Income Before Tax Ratio
| 0.257 | 0.3 | 0.273 | 0.257 | 0.255 | 0.231 | 0.225 | 0.204 | 0.223 | 0.21 | 0.197 | 0.229 | 0.139 | 0.157 | 0.237 | 0.154 | 0.149 | 0 | 0 | 0 |
Income Tax Expense
| 31.389 | 32.077 | 23.171 | 22.219 | 20.738 | 17.423 | 19.038 | 14.429 | 15.223 | 13.647 | 10.952 | 11.405 | 6.773 | 5.944 | 9.331 | 8.063 | 9.485 | 0 | 0 | 0 |
Net Income
| 103.823 | 113.973 | 90.9 | 69.387 | 70.306 | 57.055 | 47.574 | 39.098 | 40.422 | 31.245 | 26.536 | 30.247 | 15.488 | 18.657 | 27.874 | 13.537 | 28.393 | 0 | 0 | 0 |
Net Income Ratio
| 0.197 | 0.234 | 0.218 | 0.195 | 0.197 | 0.177 | 0.161 | 0.149 | 0.162 | 0.146 | 0.139 | 0.166 | 0.097 | 0.119 | 0.178 | 0.096 | 0.224 | 0 | 0 | 0 |
EPS
| 5.68 | 6.25 | 4.99 | 3.81 | 3.87 | 3.14 | 2.62 | 2.15 | 2.23 | 1.73 | 1.47 | 1.66 | 0.85 | 1.02 | 1.51 | 0.76 | 1.51 | 0.95 | 0.63 | 0.47 |
EPS Diluted
| 5.67 | 6.24 | 4.98 | 3.8 | 3.86 | 3.13 | 2.62 | 2.15 | 2.23 | 1.73 | 1.47 | 1.66 | 0.85 | 1.02 | 1.51 | 0.76 | 1.51 | 0.95 | 0.63 | 0.47 |
EBITDA
| 155.099 | 169.46 | 137.676 | 114.894 | 109.489 | 87.363 | 80.337 | 65.604 | 72.308 | 53.911 | 45.533 | 47.932 | 33.823 | 38.654 | 51.443 | 36.634 | 26.577 | 99.626 | 81.565 | 76.168 |
EBITDA Ratio
| 0.295 | 0.348 | 0.33 | 0.323 | 0.307 | 0.27 | 0.271 | 0.25 | 0.289 | 0.252 | 0.239 | 0.263 | 0.212 | 0.247 | 0.328 | 0.261 | 0.21 | 1.021 | 1.01 | 1.011 |